Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Alonso

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Atherosclerosis|March 24, 2024
Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up studyRodrigo Alonso, Raquel Arroyo-Olivares, Jose Luis Díaz-Díaz, et al.
Journal of Clinical Lipidology|December 18, 2021
Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussionRaul D Santos, Alberto Lorenzatti, Pablo Corral, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 22, 2020
COVID-19 in lung transplant recipients: A multicenter studyBerta Saez-Giménez, Cristina Berastegui, Miriam Barrecheguren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2022
Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients With Coronavirus Disease 2019: Impact on the Length of Hospital Stay and MortalityRodrigo Alonso-Navarro, Genoveva Cuesta, Marta Santos, et al.
International Journal of Cardiology|August 22, 2015
Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART studyFrancisco Fuentes, Juan F Alcala-Diaz, Gerald F Watts, et al.
Archivos De Bronconeumologia|March 21, 2022
Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV InfectionVíctor Monforte, Helena Sintes, Piedad Ussetti, et al.
Archivos De Bronconeumologia|February 8, 2021
Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational StudyVíctor Monforte, Piedad Ussetti, Raquel Castejón, et al.
European Journal of Preventive Cardiology|December 5, 2021
A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohortLeopoldo Pérez de Isla, Gerald F Watts, Ovidio Muñiz-Grijalvo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2016
Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study)Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, et al.
Archivos De Bronconeumologia|June 14, 2022
Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational StudyVíctor Monforte, Piedad Ussetti, Raquel Castejón, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Atherosclerosis|March 24, 2024
Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up studyRodrigo Alonso, Raquel Arroyo-Olivares, Jose Luis Díaz-Díaz, et al.
Journal of Clinical Lipidology|December 18, 2021
Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussionRaul D Santos, Alberto Lorenzatti, Pablo Corral, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 22, 2020
COVID-19 in lung transplant recipients: A multicenter studyBerta Saez-Giménez, Cristina Berastegui, Miriam Barrecheguren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2022
Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients With Coronavirus Disease 2019: Impact on the Length of Hospital Stay and MortalityRodrigo Alonso-Navarro, Genoveva Cuesta, Marta Santos, et al.
International Journal of Cardiology|August 22, 2015
Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART studyFrancisco Fuentes, Juan F Alcala-Diaz, Gerald F Watts, et al.
Archivos De Bronconeumologia|March 21, 2022
Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV InfectionVíctor Monforte, Helena Sintes, Piedad Ussetti, et al.
Archivos De Bronconeumologia|February 8, 2021
Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational StudyVíctor Monforte, Piedad Ussetti, Raquel Castejón, et al.
European Journal of Preventive Cardiology|December 5, 2021
A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohortLeopoldo Pérez de Isla, Gerald F Watts, Ovidio Muñiz-Grijalvo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2016
Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study)Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, et al.
Archivos De Bronconeumologia|June 14, 2022
Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational StudyVíctor Monforte, Piedad Ussetti, Raquel Castejón, et al.
Pageof 23